Science Explorer Back to mapMap
Discussion
Researcher · Progenics Pharmaceuticals (United States) · United States

Tess E. Lin

Tess E. Lin publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Prostate Cancer Treatment and Research, Adrenal and Paraganglionic Tumors and Cancer, Hypoxia, and Metabolism.

OpenAlex
World rank
#1,842,929
of 7,710,434 ranked researchers
Rank in United States
#565,002
of 1,627,098
Works
26
Citations
1.2k
Citations per work
48.0
h-index
7
i10-index 6Top 71% in Pulmonary and Respiratory Medicine
Tess E. Lin

What does Tess E. Lin research?

Tess E. Lin's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 18 works · 69.3% of their workMedicine: 18 works · 69.3% of their workPulmonary and Respiratory Medicine: 7 works · 26.9% of their workSurgery: 4 works · 15.4% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 13.5% of their workNeurology: 2 works · 7.7% of their workEndocrinology, Diabetes and Metabolism: 2 works · 5.8% of their workEverything else: 5 works · 19.2% of their workLife Sciences: 3 works · 11.5% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.5% of their workCancer Research: 3 works · 11.5% of their workTHEIR WORKTess E. Lin26works
Life Sciences12%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1869.3%
  2. Everything else519.2%
    1. Biochemistry, Genetics and Molecular Biology311.5%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Surgery15% of their works
  3. 3Radiology, Nuclear Medicine and Imaging14% of their works
  4. 4Cancer Research12% of their works
  5. 5Neurology8% of their works
  6. 6Endocrinology, Diabetes and Metabolism6% of their works

Research topics

Which keywords describe Tess E. Lin's research?

The keywords of their largest research topics: Genetic Mutations, Immunotherapy, Prostate Cancer, Androgen Receptor, Genomic Profiling, Paraganglioma, Pheochromocytoma and HIF-1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Genetic Mutations173 topics
  2. Immunotherapy112 topics
  3. Prostate Cancer112 topics
  4. Androgen Receptor71 topic
  5. Genomic Profiling71 topic
  6. Paraganglioma61 topic
  7. Pheochromocytoma61 topic
  8. HIF-151 topic
  9. Warburg Effect51 topic
  10. ALK41 topic
  11. Neuroblastoma41 topic
  12. Radiation Therapy41 topic
  13. Screening41 topic
  14. Hyponatremia31 topic
  15. PET Imaging31 topic
  16. Radiopharmaceuticals31 topic
  17. Vasopressin31 topic
  18. Aquaporins21 topic
  19. Water Channels21 topic

Where does Tess E. Lin work?

Tess E. Lin's main affiliation in the publication record is Progenics Pharmaceuticals (United States), United States.

How many publications and citations does Tess E. Lin have?

OpenAlex counts 26 works and 1,248 citations for Tess E. Lin, an h-index of 7, ranking #1,842,929 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tess E. Lin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.